Neurotensin(8-13)

Neurotensin(8-13) is a biologically active peptide fragment derived from the C-terminal region of the neurotensin neuropeptide, which is widely distributed in the central nervous system and peripheral tissues. As a truncated yet functionally significant segment, it retains the core bioactivity of the full-length peptide, making it a valuable tool for dissecting neurotensin-mediated signaling pathways. Its high affinity for neurotensin receptors, particularly NTS1 and NTS2, underpins its importance in neuropharmacological research, receptor binding studies, and investigations into neuromodulatory processes. The unique sequence and stability of Neurotensin(8-13) facilitate its use in a range of experimental models to elucidate the physiological and biochemical roles of neurotensin-derived peptides.

Receptor binding assays: Neurotensin(8-13) is extensively utilized as a selective ligand in receptor binding studies to characterize the pharmacological properties of neurotensin receptors. Its ability to mimic the endogenous ligand's interaction with NTS1 and NTS2 allows researchers to quantify receptor density, assess binding affinity, and evaluate the specificity of receptor antagonists or agonists. This application is fundamental in mapping neurotensin receptor distribution in various tissues and cell lines, providing insights into receptor functionality and regulation.

Signal transduction research: The peptide fragment serves as a potent activator in studies of intracellular signaling cascades initiated by neurotensin receptor activation. By applying Neurotensin(8-13) to cultured cells or tissue preparations, investigators can monitor downstream events such as phospholipase C activation, calcium mobilization, and MAPK pathway modulation. These experiments are crucial for delineating the molecular mechanisms underlying neurotensin's neuromodulatory and neuroendocrine effects, as well as for identifying potential targets for pharmacological intervention.

Neuropharmacological modeling: As a stable and active mimic of the endogenous neurotensin ligand, Neurotensin(8-13) is frequently employed in neuropharmacological models to study the physiological consequences of neurotensin receptor engagement. Its application enables the examination of synaptic transmission, neuronal excitability, and neurotransmitter release in both in vitro and ex vivo systems. Such studies are instrumental in advancing the understanding of neurotensin's role in modulating neural circuits involved in pain processing, thermoregulation, and behavioral responses.

Peptide structure-activity relationship (SAR) studies: The defined sequence and preserved activity of Neurotensin(8-13) make it an ideal template for structure-activity relationship investigations. By systematically modifying amino acid residues or employing analogs, researchers can probe the determinants of receptor selectivity, binding affinity, and functional efficacy. These SAR studies facilitate the rational design of novel neurotensin-based ligands with improved pharmacological profiles or tailored biological activity, supporting drug discovery and basic neuropeptide research.

Peptide synthesis and analytical standards: Due to its well-characterized structure and bioactivity, Neurotensin(8-13) is often used as a reference compound in peptide synthesis optimization and analytical validation. It serves as a benchmark for evaluating synthetic efficiency, purity assessment, and chromatographic method development. Employing this peptide as a standard ensures consistency and reliability in peptide production workflows and analytical quality control, thereby supporting robust experimental outcomes across neuropeptide research applications.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef